Argentina vs Cambodia: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Argentina
79.0%
in 2025
Cambodia
80.0%
in 2025
Argentina rank
119th
Cambodia rank
116th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Argentina
- Cambodia
How they compare
Cambodia currently reports 80.0% against 79.0% in Argentina, a difference of 1.0%.
The two have swapped places 4 times across 18 shared years of data; in 2008 it was Cambodia ahead.
Argentina ranks 119th and Cambodia ranks 116th of 192 countries.
Across the 3 decades both report, Argentina averaged higher in 1 and Cambodia in 1.
Head to head by decade
| Decade | Argentina | Cambodia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 62.6% | 40.7% | 21.9% | Argentina |
| 2020s | 77.0% | 83.5% | 6.5% | Cambodia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Argentina or Cambodia?
- Cambodia, at 80.0% against 79.0% in Argentina as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Argentina and Cambodia?
- 1.0%, with Cambodia ahead.
- How many years of comparable data are there for Argentina and Cambodia?
- 18 years are reported by both, from 2008 to 2025.
- How do Argentina and Cambodia rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Argentina ranks 119th and Cambodia ranks 116th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.